Hepatitis C and health-related quality of life among patients with hemophilia

Haematologica

Volumn 90, Issue 6, 2005, Pages

  Posthouwer, Dirk ^a   Plug, Iris ^b   Van Der Bom, Johanna G ^a,b   Fischer, Kathelijn ^a,c   Rosendaal, Frits R ^b   Mauser Bunschoten, Eveline P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Hemophilia; Hepatitis C; HRQoL; Survey

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DISEASE SEVERITY; EMOTION; EMPLOYMENT; FEMALE; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JOINT LIMITATION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NETHERLANDS; PAIN; QUALITY OF LIFE; SCHOOL CHILD; SELF REPORT; SHORT FORM 36; SOCIAL INTERACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HEALTH STATUS; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 21244485381     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Molho P, Rolland N, Lebrun T, Dirat G, Courpied JP, Croughs T, et al. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. Haemophilia 2000;6:23-32.
2. Barr RD, Saleh M, Furlong W, Horsman J, Sek J, Pai M, et al. Health status and health-related quality of life associated with hemophilia. Am J Hematol 2002; 71:152-60.
3. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999;5:378-85.
4. Trippoli S, Vaiani M, Linari S, Longo G, Morfini M, Messori A. Multivariate analysis of factors influencing quality of life and utility in patients with haemophilia. Haematologica 2001;86: 722-8.
5. Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza CR, Dusheiko GM, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet 1997;350:1425-31.
6. Makris M, Preston FE, Triger DR, Underwood JC, Choo QL, Kuo G, et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; 335:1117-9.
7. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, et al. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile Clin Ther 1994; 16:334-43.
8. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998;27:209-12.
9. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001;96:2737-44.
10. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999;29:264-70.
11. Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM, et al. Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C. Gut 2003;52:425-32
12. Ware JE Jr, Bayliss MS, Marmocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999;30:550-5.
13. Veltkamp JJ, Schrijver G, Willeumier W, van de Putte B, van Dijck H. Hemophilia in the Netherlands. Results of a survey on the medical, genetic and social situation of the Dutch hemophiliacs. Acta Med Scand Suppl 1974;572: 3-24.
14. Rosendaal FR, Varekamp I, Smit C, Brocker-Vriends AH, van Dijck H, Vandenbroucke JP, et al. Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 1989;71:71-6.
15. Plug I, Van Der Born JG, Peters M, Mauser-Bunschoten EP, Goede-Bolder A, Heijnen L, et al. Thirty years of hemophilia treatment in the Netherlands, 1972-2001. Blood 2004;104:3494-500.
16. Triemstra M, Rosendaal FR, Smit C, Van der Ploeg HM, Briet E. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med 1995;123:823-7.
17. Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med 2001;33:350-7.
18. van der Zee KI, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36: een handleiding. Groningen, the Netherlands: Noordelijk Centrum voor Gezondheidsvraagstukken. 1993.
19. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
20. Ware JE Jr, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A Users Manual. Nosto, MA. The Health Institute, New England Medical Center. 1994.
21. Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, Vargas V, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003;39:231-8.
22. Gailegos-Orozco JF, Fuentes AP, Gerardo AJ, Perez-Pruna C, Hinojosa-Becerril C, Sixtos-Alonso MS, et al. Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003;34:124-9.
23. Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology 2004;39: 74-80.
24. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999;30:1299-301.
25. Posthouwer D, Plug I, van der Bom JG, Fischer K, Rosendaal FR, Mauser-Bunschoten EP. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment. Haemophilia 2005;11:270-5.